Complimentary registration is available to qualified institutional (buy and sell-side), private equity, and venture investors.
BIO events attract the most sophisticated investors in the life science community and provide a robust forum for this community to engage in the advancement of promising technologies that improve and save lives. BIO is pleased to provide complimentary registration to qualified investors under BIO’s investor policy which has been modified.
Qualified investors are defined as institutional, private equity, angel and venture investors with funds on-hand, whose primary activity is direct investment in research and development companies (e.g., hedge fund, mutual fund, or venture fund). Equity research analysts from investment banking institutions and buy-side analysts also qualify as investors. At BIO’s discretion, qualified investors may also include crowdfunding platforms and, potentially, individuals who qualify as “accredited investors,” which have gained importance to the biotech industry under the JOBS Act.
The fund name, portfolio type, or other helpful information is needed for BIO to process your registration appropriately. Receipt of complimentary registration for a prior year's event does not automatically qualify a registrant for complimentary registration in 2018.
A more detailed list of criteria for investor registration is available here.